vitamin K1 phylloquinone low dose
Selected indexed studies
- Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. (Osteoporos Int, 2013) [PMID:23525894]
- Pharmacokinetics of vitamin K1 in low-birth-weight neonates. (Dev Pharmacol Ther, 1985) [PMID:4042792]
- Antagonism of warfarin-induced hypoprothrombinemia with use of low-dose subcutaneous vitamin K1. (J Clin Pharmacol, 1997) [PMID:9378848]
_Worker-drafted node — pending editorial review._
Connections
vitamin K1 phylloquinone low dose helps
vitamin K1 phylloquinone low dose protects against
Sources
- Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. (2013) pubmed
- Evaluation of Response to High-Dose Intravenous Vitamin K Administration. (2023) pubmed
- Vitamin K and cardiovascular complications in chronic kidney disease patients. (2021) pubmed
- Pharmacokinetics of vitamin K1 in low-birth-weight neonates. (1985) pubmed
- Antagonism of warfarin-induced hypoprothrombinemia with use of low-dose subcutaneous vitamin K1. (1997) pubmed
- Does intramuscular vitamin K1 act as an unintended depot preparation? (1996) pubmed
- Vitamin K1 supplementation to improve the stability of anticoagulation therapy with vitamin K antagonists: a dose-finding study. (2011) pubmed
- Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease. (2005) pubmed
- Low-dose vitamin K1 versus short-term with holding of acenocoumarol in the treatment of excessive anticoagulation episodes induced by acenocoumarol. A retrospective comparative study. (1998) pubmed
- Reversal of excessive oral anticoagulation with a low oral dose of vitamin K1 compared with acenocoumarine discontinuation. A prospective, randomized, open study. (2001) pubmed